Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-03-17 06:04 am Purchase | 2023-03-09 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,644,573 5.000% | 766,276![]() (+26.62%) | Filing History |
2023-02-14 08:27 am Sale | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 3,399,921 4.800% | -151,850![]() (-4.28%) | Filing History |
2023-02-10 11:48 am Purchase | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 8,213,131 11.650% | 229,730![]() (+2.88%) | Filing History |
2023-02-10 06:10 am Sale | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 2,878,297 4.100% | -1,080,915![]() (-27.30%) | Filing History |
2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Beam Therapeutics Inc. BEAM | VANGUARD GROUP INC | 6,273,630 8.900% | 1,576,365![]() (+33.56%) | Filing History |
2023-02-09 08:14 am Purchase | 2023-02-09 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 7,769,016 11.024% | 1,779,318![]() (+29.71%) | Filing History |
2023-02-02 4:05 pm Purchase | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 5,238,280 7.400% | 1,175,486![]() (+28.93%) | Filing History |
2022-07-14 3:55 pm Purchase | 2022-07-05 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners L.P. | 3,551,771 5.100% | 3,551,771![]() (New Position) | Filing History |
2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | Redmile Group LLC | 1,885,850 2.800% | -1,892,412![]() (-50.09%) | Filing History |
2022-02-14 4:04 pm Sale | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | HHLR ADVISORS LTD. | 0 0.000% | -2,966,403![]() (Position Closed) | Filing History |
2022-02-14 12:04 pm Sale | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 5,871,150 8.600% | -2,371,889![]() (-28.77%) | Filing History |
2022-02-14 06:38 am Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,959,212 5.800% | 604,571![]() (+18.02%) | Filing History |
2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | VANGUARD GROUP INC | 4,697,265 6.890% | 4,697,265![]() (New Position) | Filing History |
2022-02-09 2:05 pm Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 7,983,401 11.720% | 1,676,852![]() (+26.59%) | Filing History |
2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 5,989,698 8.790% | -828,724![]() (-12.15%) | Filing History |
2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 4,062,794 6.000% | 970,983![]() (+31.40%) | Filing History |
2022-01-24 08:40 am Sale | 2022-01-21 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 6,818,422 10.007% | -510,164![]() (-6.96%) | Filing History |
2021-06-10 1:14 pm Purchase | 2021-05-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 6,306,549 10.080% | 6,306,549![]() (New Position) | Filing History |
2021-04-09 6:02 pm Sale | 2021-03-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 3,091,811 5.000% | -67,699![]() (-2.14%) | Filing History |
2021-02-16 4:18 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | HHLR ADVISORS LTD. | 2,966,403 5.100% | 2,966,403![]() (New Position) | Filing History |